Intravenous Immunoglobulin In Solid-Organ Transplantation

Amy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaThe survival of kidney and lung allografts continues to be threatened by sensitization, donor-specific antibody (DSA) formation, and antibody-mediated rejection (AMR). Intravenous immunoglobulin (IVIG) has been incorporated into 3 major clinical contexts central to transplant medicine: des